PT88556B
(pt)
*
|
1987-09-28 |
1992-11-30 |
Smithkline Biolog |
Processo de integracao genomica estavel e de expressao de uma sequencia de cadificacao estranha, em leveduras
|
KR0184860B1
(ko)
|
1988-11-11 |
1999-04-01 |
메디칼 리써어치 카운실 |
단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법)
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
US6291161B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertiore
|
US6680192B1
(en)
|
1989-05-16 |
2004-01-20 |
Scripps Research Institute |
Method for producing polymers having a preselected activity
|
US6969586B1
(en)
*
|
1989-05-16 |
2005-11-29 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
US6291159B1
(en)
*
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for producing polymers having a preselected activity
|
GB8920211D0
(en)
*
|
1989-09-07 |
1989-10-18 |
Ici Plc |
Diagnostic method
|
WO1991009957A1
(en)
*
|
1989-12-22 |
1991-07-11 |
E.I. Du Pont De Nemours And Company |
Site-specific recombination of dna in plant cells
|
US5658772A
(en)
*
|
1989-12-22 |
1997-08-19 |
E. I. Du Pont De Nemours And Company |
Site-specific recombination of DNA in plant cells
|
ES2080957T3
(es)
*
|
1990-07-13 |
1996-02-16 |
Transkaryotic Therapies Inc |
Metodo para escrutar una genoteca.
|
US5580734A
(en)
*
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
WO1992015694A1
(en)
*
|
1991-03-08 |
1992-09-17 |
The Salk Institute For Biological Studies |
Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
|
WO1992022650A1
(en)
*
|
1991-06-17 |
1992-12-23 |
Life Technologies, Inc. |
Recombination-facilitated multiplex analysis of dna fragments
|
WO1993001283A1
(en)
*
|
1991-07-08 |
1993-01-21 |
The United States Of America As Represented By The Secretary Of Agriculture |
Selection-gene-free transgenic plants
|
EP0626999A4
(en)
*
|
1992-01-24 |
1997-04-09 |
Life Technologies Inc |
Modulation of enzyme activities in the -i(in vivo) cloning of dna.
|
AU4401993A
(en)
*
|
1992-06-04 |
1993-12-30 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6261808B1
(en)
|
1992-08-04 |
2001-07-17 |
Replicon, Inc. |
Amplification of nucleic acid molecules via circular replicons
|
US5834202A
(en)
*
|
1992-08-04 |
1998-11-10 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
WO1994003624A1
(en)
*
|
1992-08-04 |
1994-02-17 |
Auerbach Jeffrey I |
Methods for the isothermal amplification of nucleic acid molecules
|
US5614389A
(en)
*
|
1992-08-04 |
1997-03-25 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
US5733733A
(en)
*
|
1992-08-04 |
1998-03-31 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
GB9302798D0
(en)
*
|
1993-02-12 |
1993-03-31 |
Medical Res Council |
Improvements in or relating to cloning dna
|
US5843744A
(en)
*
|
1993-07-08 |
1998-12-01 |
Ecogen Inc. |
Bacillus thuringiensis Tn5401 proteins
|
US5441884A
(en)
*
|
1993-07-08 |
1995-08-15 |
Ecogen Inc. |
Bacillus thuringiensis transposon TN5401
|
US5731172A
(en)
*
|
1994-03-09 |
1998-03-24 |
Sumitomo Pharmaceuticals Company, Ltd. |
Recombinant adenovirus and process for producing the same
|
US5723765A
(en)
*
|
1994-08-01 |
1998-03-03 |
Delta And Pine Land Co. |
Control of plant gene expression
|
EG23907A
(en)
*
|
1994-08-01 |
2007-12-30 |
Delta & Pine Land Co |
Control of plant gene expression
|
CA2197242A1
(en)
*
|
1994-08-18 |
1996-02-29 |
Joan S. Brugge |
Regulatable elimination of gene expression, gene product function and engineered host cells
|
JP4216350B2
(ja)
*
|
1994-09-19 |
2009-01-28 |
大日本住友製薬株式会社 |
動物細胞感染用の組換えdnaウイルスベクター
|
JP3770333B2
(ja)
*
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えdnaウイルスおよびその製造方法
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6091001A
(en)
*
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US5629159A
(en)
*
|
1995-06-07 |
1997-05-13 |
California Institute Of Technology |
Immortalization and disimmortalization of cells
|
US6974694B2
(en)
*
|
1995-06-07 |
2005-12-13 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
US6720140B1
(en)
|
1995-06-07 |
2004-04-13 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
US6964861B1
(en)
*
|
1998-11-13 |
2005-11-15 |
Invitrogen Corporation |
Enhanced in vitro recombinational cloning of using ribosomal proteins
|
US6143557A
(en)
*
|
1995-06-07 |
2000-11-07 |
Life Technologies, Inc. |
Recombination cloning using engineered recombination sites
|
US20060110798A1
(en)
*
|
1995-06-07 |
2006-05-25 |
Graham Frank L |
Cells expressing recombinase useful for adenovirus vector production and control of gene expression
|
JP4020429B2
(ja)
|
1995-06-07 |
2007-12-12 |
インヴィトロジェン コーポレーション |
操作された組換え部位を使用する組換えクローニング
|
US5801030A
(en)
*
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
US6051409A
(en)
|
1995-09-25 |
2000-04-18 |
Novartis Finance Corporation |
Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
|
US7153652B2
(en)
*
|
1995-10-02 |
2006-12-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mismatch repair detection
|
US6406847B1
(en)
*
|
1995-10-02 |
2002-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mismatch repair detection
|
JP2000500341A
(ja)
*
|
1995-11-13 |
2000-01-18 |
ユニバーシティ・オブ・ロチェスター |
組換え基質による哺乳類体細胞モザイク現象の生成
|
WO1997025446A1
(en)
*
|
1996-01-05 |
1997-07-17 |
Genetic Therapy, Inc. |
Recombinase-mediated generation of adenoviral vectors
|
US6087129A
(en)
*
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
WO1997032481A1
(en)
|
1996-03-07 |
1997-09-12 |
The Regents Of The University Of California |
Helper-free, totally defective adenovirus for gene therapy
|
US6132989A
(en)
*
|
1996-06-03 |
2000-10-17 |
University Of Washington |
Methods and compositions for enhanced stability of non-adenoviral DNA
|
US6534314B1
(en)
|
1996-06-14 |
2003-03-18 |
Massachusetts Institute Of Technology |
Methods and compositions for transforming cells
|
US5928914A
(en)
*
|
1996-06-14 |
1999-07-27 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Methods and compositions for transforming cells
|
US6255071B1
(en)
|
1996-09-20 |
2001-07-03 |
Cold Spring Harbor Laboratory |
Mammalian viral vectors and their uses
|
US6025192A
(en)
*
|
1996-09-20 |
2000-02-15 |
Cold Spring Harbor Laboratory |
Modified retroviral vectors
|
US7332338B2
(en)
|
1996-10-04 |
2008-02-19 |
Lexicon Pharmaceuticals, Inc. |
Vectors for making genomic modifications
|
US20040072243A1
(en)
*
|
1996-10-11 |
2004-04-15 |
Lexicon Genetics Incorporated |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
US6066778A
(en)
*
|
1996-11-06 |
2000-05-23 |
The Regents Of The University Of Michigan |
Transgenic mice expressing APC resistant factor V
|
US5994620A
(en)
*
|
1996-12-10 |
1999-11-30 |
The Jackson Laboratory |
Induced chromosomal deletion
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
US6787319B2
(en)
*
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
US6774279B2
(en)
*
|
1997-05-30 |
2004-08-10 |
Carnegie Institution Of Washington |
Use of FLP recombinase in mice
|
US6284944B1
(en)
|
1997-08-29 |
2001-09-04 |
Cephalon, Inc, |
Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
|
US20040019923A1
(en)
*
|
1997-10-16 |
2004-01-29 |
Ivarie Robert D. |
Exogenous proteins expressed in avians and their eggs
|
US20090074718A1
(en)
*
|
1997-10-16 |
2009-03-19 |
Ivarie Robert D |
Avian derived erythropoietin
|
KR20010031190A
(ko)
*
|
1997-10-16 |
2001-04-16 |
아비게닉스, 인코포레이티드 |
조류 트랜스제네시스용 매그넘-특이적 프로모터를함유하는 벡터
|
US7511120B2
(en)
*
|
1997-10-16 |
2009-03-31 |
Synageva Biopharma Corp. |
Glycosylated G-CSF obtained from a transgenic chicken
|
US8563803B2
(en)
*
|
1997-10-16 |
2013-10-22 |
Synageva Biopharma Corp. |
Method of making protein in an egg of a transgenic chicken
|
US7129390B2
(en)
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
WO1999021977A1
(en)
*
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Recombinational cloning using nucleic acids having recombination sites
|
US7351578B2
(en)
|
1999-12-10 |
2008-04-01 |
Invitrogen Corp. |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
AU757930B2
(en)
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
US6436707B1
(en)
|
1998-03-27 |
2002-08-20 |
Lexicon Genetics Incorporated |
Vectors for gene mutagenesis and gene discovery
|
US6808921B1
(en)
|
1998-03-27 |
2004-10-26 |
Lexicon Genetics Incorporated |
Vectors for gene mutagenesis and gene discovery
|
AU8592298A
(en)
*
|
1998-07-24 |
2000-02-14 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
TWI255853B
(en)
*
|
1998-08-21 |
2006-06-01 |
Kirin Brewery |
Method for modifying chromosomes
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
US6395511B1
(en)
|
1998-11-27 |
2002-05-28 |
Darwin Discovery, Ltd. |
Nucleic acids encoding a novel family of TGF-β binding proteins from humans
|
EP2119788A1
(de)
|
1999-03-02 |
2009-11-18 |
Life Technologies Corporation |
Zusammensetzungen und Verfahren zur Verwendung beim Rekombinationsklonen von Nukleinsäuren
|
EP1159402A4
(de)
*
|
1999-03-02 |
2003-01-29 |
Invitrogen Corp |
ZELLEN, WELCHE RESISTENT GEGENüBER TOXISCHEN GENEN SIND UND DEREN ANWENDUNGEN
|
US6890726B1
(en)
|
1999-04-06 |
2005-05-10 |
Oklahoma Medical Research Foundation |
Method for selecting recombinase variants with altered specificity
|
AU781628B2
(en)
*
|
1999-07-14 |
2005-06-02 |
Clontech Laboratories, Inc. |
Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
|
EP2031068A1
(de)
*
|
1999-07-14 |
2009-03-04 |
Transgenic Inc. |
Fallenvektor und Gen-Trapping-Verfahren damit
|
EP1228237A1
(de)
|
1999-11-01 |
2002-08-07 |
Chiron Corporation |
Expressionsvektoren, transfektionssysteme, und verfahren zur verwendung
|
AU1777301A
(en)
*
|
1999-11-19 |
2001-05-30 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
NZ530816A
(en)
|
1999-12-10 |
2005-10-28 |
Invitrogen Corp |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
DE10004996C2
(de)
*
|
2000-02-04 |
2002-09-26 |
Infineon Technologies Ag |
Vorrichtung und Verfahren zur Selbstkalibrierung von Faltungs-Analog/Digitalwandlern
|
US7517688B2
(en)
*
|
2000-02-25 |
2009-04-14 |
Stratagene California |
Method for ligating nucleic acids and molecular cloning
|
EP1504119A2
(de)
*
|
2000-02-25 |
2005-02-09 |
Stratagene California |
Verfahren zur ligation von nukleinsäuren und molekularer klonierung
|
US6580019B1
(en)
|
2000-03-09 |
2003-06-17 |
Dekalb Genetics Corporation |
Non-reciprocal recombination-mediated transgene deletion in transgenic plants
|
US6750379B2
(en)
|
2000-03-09 |
2004-06-15 |
Dekalb Genetics Corporation |
Homologous recombination-mediated transgene alterations in plants
|
EP1276500B1
(de)
|
2000-03-13 |
2011-06-08 |
Cornell Research Foundation, Inc. |
Blockieren der leukozytenemigration und entzündung durch störung mit cd99/hec2
|
US20040231006A1
(en)
*
|
2000-04-12 |
2004-11-18 |
Silver Daniel P. |
Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
|
CA2405768A1
(en)
|
2000-04-12 |
2001-10-25 |
Dana-Farber Cancer Institute |
Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
|
US7244560B2
(en)
*
|
2000-05-21 |
2007-07-17 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
JP3523245B1
(ja)
|
2000-11-30 |
2004-04-26 |
メダレックス,インコーポレーテッド |
ヒト抗体作製用トランスジェニック染色体導入齧歯動物
|
EP1356035B1
(de)
*
|
2000-12-22 |
2011-03-16 |
Kyowa Hakko Kirin Co., Ltd. |
Verfahren zur klonierung von nichtmenschliche säugern unter verwendung von reprogrammiertem donorchromatin oder donorzellen
|
US7491534B2
(en)
*
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
EP1860199B1
(de)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulierte Signalisierung von Insulinrezeptoren
|
AU2002242854A1
(en)
*
|
2001-03-21 |
2002-10-03 |
Geron Corporation |
Use of telomerase reverse transcriptase to create homozygous knockout animals
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
WO2002081711A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Cropdesign N.V. |
The use of double and opposite recombination sites for the single step cloning of two dna segments
|
WO2002086144A2
(en)
*
|
2001-04-19 |
2002-10-31 |
Invitrogen Corporation |
Compositions and methods for recombinational cloning of nucleic acid molecules
|
US20020188965A1
(en)
|
2001-04-20 |
2002-12-12 |
Zou-Yu Zhao |
Methods of transforming plants
|
CA2508763C
(en)
|
2001-05-11 |
2012-01-24 |
Kirin Beer Kabushiki Kaisha |
Human antibody producing mouse and method for producing human antibody using the same
|
EP1451344A4
(de)
*
|
2001-05-21 |
2005-03-23 |
Invitrogen Corp |
Zusammensetzungen und verfahren zur verwendung bei der isolierung von nukleinsäuremolekülen
|
CA2441937A1
(en)
*
|
2001-05-30 |
2002-12-05 |
Chromos Molecular Systems, Inc. |
Chromosome-based platforms
|
US20030092183A1
(en)
*
|
2001-09-21 |
2003-05-15 |
Fisher Katherine E. |
Rapid creation of gene targeting vectors using homologous recombination in yeast
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
ES2350248T3
(es)
|
2001-10-01 |
2011-01-20 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Procedimiento de producción de bibliotecas de proteínas y de selección de proteínas a partir de las mismas.
|
DE10211063A1
(de)
|
2002-03-13 |
2003-10-09 |
Axaron Bioscience Ag |
Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
JP2006506972A
(ja)
*
|
2002-07-26 |
2006-03-02 |
ジェネコポエイア・インコーポレイテッド |
cDNAクローンを迅速に発現させてスクリーニングするための方法および核酸ベクター
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US20040229230A1
(en)
*
|
2002-08-27 |
2004-11-18 |
Sleckman Barry P. |
Method for gene isolation by Cre-trap cloning
|
US7285699B2
(en)
*
|
2002-10-07 |
2007-10-23 |
Stowers Institute For Medical Research |
Ends-out gene targeting method
|
US20040170614A1
(en)
*
|
2002-10-30 |
2004-09-02 |
Gail Bishop |
Somatic cell gene targeting vectors and methods of use thereof
|
US20030175968A1
(en)
*
|
2002-10-30 |
2003-09-18 |
Golic Kent G. |
Gene targeting method
|
NZ539459A
(en)
*
|
2002-11-08 |
2009-02-28 |
Kirin Pharma Kk |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
US7078234B2
(en)
|
2002-12-18 |
2006-07-18 |
Monsanto Technology Llc |
Maize embryo-specific promoter compositions and methods for use thereof
|
US20060275766A1
(en)
*
|
2003-01-07 |
2006-12-07 |
Haurum John S |
Method for manufacturing recombinant polyclonal proteins
|
BRPI0406678A
(pt)
*
|
2003-01-07 |
2005-12-20 |
Symphogen As |
Método para produzir proteìnas policlonais recombinantes
|
US20040133944A1
(en)
*
|
2003-01-08 |
2004-07-08 |
Delta And Pine Land Company |
Seed oil suppression to enhance yield of commercially important macromolecules
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
US7271313B2
(en)
*
|
2003-04-09 |
2007-09-18 |
The Brigham And Women's Hospital, Inc. |
Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss
|
EP1921152A1
(de)
|
2003-05-05 |
2008-05-14 |
Monsanto Technology, LLC |
Transgene Pflanzen mit Glycin-Betain-spezifischem Promoter
|
US7304203B2
(en)
*
|
2003-09-18 |
2007-12-04 |
Mayo Foundation For Medical Education And Research |
Transgenic TIEG non-human animals
|
CA2540244A1
(en)
*
|
2003-09-30 |
2005-04-14 |
Lexicon Genetics Incorporated |
Methods and compositions for defining gene function
|
DE602004029089D1
(de)
|
2003-10-02 |
2010-10-21 |
Monsanto Technology Llc |
Stapeln von merkmalen zur verbesserung von nutzpflanzen in transgenen pflanzen
|
EP2287341B1
(de)
|
2003-12-01 |
2013-02-13 |
Life Technologies Corporation |
Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon
|
US20050235370A1
(en)
*
|
2003-12-12 |
2005-10-20 |
National Health Research Institutes |
Spatiotemporally controlled adult somatic mutagenesis system
|
ATE415088T1
(de)
|
2003-12-30 |
2008-12-15 |
Ulleval Universitetssykehus Hf |
Nichtmenschliches säugetier mit modifiziertem serca2-gen sowie verfahren, zellen, gene und vektoren hierfür
|
US7683237B2
(en)
|
2004-02-10 |
2010-03-23 |
Monsanto Technology Llc |
Maize seed with synergistically enhanced lysine content
|
AR047598A1
(es)
|
2004-02-10 |
2006-01-25 |
Monsanto Technology Llc |
Semilla de maiz transgenica con mayor contenido de aminoacidos
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
AU2005244258B2
(en)
|
2004-04-09 |
2010-07-01 |
Monsanto Technology Llc |
Compositions and methods for control of insect infestations in plants
|
NZ550106A
(en)
|
2004-04-22 |
2009-06-26 |
Kyowa Hakko Kirin Co Ltd |
Transgenic animals and uses thereof
|
ES2332524T3
(es)
|
2004-07-20 |
2010-02-08 |
Symphogen A/S |
Un procedimiento para la caracterizacion de una linea celular policlonal.
|
US7582741B2
(en)
|
2004-07-26 |
2009-09-01 |
University Of Massachusetts |
Conditional disruption of dicer1 in cell lines and non-human mammals
|
CA2579790A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Npc1l1 and npc1l1 inhibitors and methods of use thereof
|
US20060075522A1
(en)
|
2004-07-31 |
2006-04-06 |
Jaclyn Cleveland |
Genes and uses for plant improvement
|
CA2584814A1
(en)
*
|
2004-10-22 |
2006-05-04 |
Therapeutic Human Polyclonals, Inc. |
Suppression of endogenous immunoglobulin expression in non-human transgenic animals
|
US7501275B2
(en)
*
|
2004-10-27 |
2009-03-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Yeast transformation system
|
US20100022402A1
(en)
*
|
2004-11-23 |
2010-01-28 |
Sancar Adhya |
Methods and Compositions for the In Vitro High-Throughput Detection of Protein/Protein Interactions
|
US20080244765A1
(en)
*
|
2004-12-16 |
2008-10-02 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for pollination disruption
|
CA2875402C
(en)
|
2004-12-21 |
2021-09-28 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
ES2459369T3
(es)
|
2004-12-21 |
2014-05-09 |
Monsanto Technology Llc |
Plantas transgénicas con rasgos agronómicos potenciados
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
AU2006203892B2
(en)
|
2005-01-07 |
2011-03-24 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method to trigger RNA interference
|
AU2006204997B2
(en)
|
2005-01-12 |
2011-09-01 |
Monsanto Technology, Llc |
Genes and uses for plant improvement
|
US20060174362A1
(en)
|
2005-02-01 |
2006-08-03 |
Origen Therapeutics, Inc. |
Long-term culture of avian primordial germ cells (PGCs)
|
EP2478760A1
(de)
|
2005-05-10 |
2012-07-25 |
Monsanto Technology LLC |
Gene und ihre Verwendung zur Pflanzenverbesserung
|
US8088382B2
(en)
*
|
2005-07-05 |
2012-01-03 |
Cornell Research Foundation, Inc. |
Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies
|
WO2007053207A2
(en)
*
|
2005-07-07 |
2007-05-10 |
The General Hospital Corporation |
Methods for controlling stem cell differentiation
|
US9121028B2
(en)
*
|
2005-09-09 |
2015-09-01 |
Monsanto Technology Llc |
Selective gene expression in plants
|
EP2426208B1
(de)
|
2005-09-16 |
2016-11-09 |
Monsanto Technology, LLC |
Verfahren zur genetischen Kontrolle von Insektenplagen bei Pflanzen und Zusammensetzungen dafür
|
US8853489B2
(en)
|
2005-09-16 |
2014-10-07 |
Devgen Nv |
Transgenic plant-based methods for plant pests using RNAi
|
ATE542912T1
(de)
|
2005-10-03 |
2012-02-15 |
Monsanto Technology Llc |
Transgene pflanzensamen mit erhöhtem lysin
|
US20070243617A1
(en)
*
|
2005-10-13 |
2007-10-18 |
Holt Robert A |
Modular genomes for synthetic biology and metabolic engineering
|
US20070143881A1
(en)
*
|
2005-12-16 |
2007-06-21 |
Pioneer Hi-Bred International, Inc. |
Methods and Compositions for Improving the Efficiency of Site-Specific Polynucleotide Exchange
|
EP2484769A3
(de)
|
2005-12-21 |
2012-09-19 |
Monsanto Technology LLC |
Transgene Pflanzen mit verbesserten agronomischen Merkmalen
|
EP2044109B1
(de)
|
2006-02-10 |
2014-05-21 |
Monsanto Technology, LLC |
Identifizierung und verwendung von zielgenen zur steuerung pflanzenparasitärer nematoden
|
WO2007095496A2
(en)
|
2006-02-13 |
2007-08-23 |
Monsanto Technology Llc |
Selecting and stabilizing dsrna constructs
|
US20100070186A1
(en)
*
|
2006-03-15 |
2010-03-18 |
Soper Bryan R |
Methods of screening for and mapping phenotypic and genotypic variations in cells
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
US20070250941A1
(en)
*
|
2006-03-27 |
2007-10-25 |
Genentech, Inc. |
VEGF Receptor Conditional Knockout Animals and Methods of Use
|
US7919322B2
(en)
*
|
2006-03-29 |
2011-04-05 |
Sigma-Aldrich Co. |
Targeted deletions using retroelement-mediated placement of recombination sites
|
EP2010226B1
(de)
|
2006-04-07 |
2014-01-15 |
The Research Foundation of State University of New York |
Transcobalaminrezeptor-Polypeptide, -Nukleinsäuren und -Modulatoren sowie entsprechende Verfahren zur Verwendung für die Modulation von Zellwachstum und die Behandlung von Krebs und Cobalaminmangel
|
BRPI0709783B1
(pt)
|
2006-05-09 |
2017-05-30 |
Univ Missouri |
minicromossomos artificiais de planta produzidos por truncagem de telômero e método de produção dos mesmos
|
US20110252501A1
(en)
|
2006-08-17 |
2011-10-13 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
US8053191B2
(en)
|
2006-08-31 |
2011-11-08 |
Westend Asset Clearinghouse Company, Llc |
Iterative nucleic acid assembly using activation of vector-encoded traits
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
WO2008091680A2
(en)
*
|
2007-01-25 |
2008-07-31 |
The General Hospital Corporation |
Methods for controlling stem cell differentiation
|
WO2008091311A1
(en)
|
2007-01-26 |
2008-07-31 |
Synageva Biopharma Corp |
Transgene expression in avians
|
EP2113029A4
(de)
*
|
2007-02-09 |
2010-06-02 |
Univ Utah Res Found |
In vivo genomweite mutagenese
|
EP2126105A4
(de)
*
|
2007-02-20 |
2010-11-03 |
Anaptysbio Inc |
Somatische hyperpermutationssysteme
|
EP2120544A4
(de)
*
|
2007-03-09 |
2010-12-15 |
Univ Missouri |
Verfahren für bedingte und induzierbare transgenexpression zur lenkung der entwicklung von stammzellen
|
DE102007041655A1
(de)
|
2007-09-03 |
2009-03-05 |
Medicyte Gmbh |
Vermehrung von primären Zellen und deren Verwendung
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
EP2193146B1
(de)
|
2007-09-14 |
2016-05-25 |
Adimab, LLC |
Synthetische antikörperbibliotheken mit rationalem design und ihre verwendung
|
PL2612868T3
(pl)
|
2007-11-01 |
2018-12-31 |
Astellas Pharma Inc. |
Immunosupresyjne polipeptydy i kwasy nukleinowe
|
FR2927089B1
(fr)
|
2008-02-05 |
2011-03-25 |
Inst Nat De La Rech Agronomique Inra |
Procede d'integration ciblee de multicopies d'un gene d'interet dans une souche de yarrowia
|
US20090233809A1
(en)
*
|
2008-03-04 |
2009-09-17 |
Affymetrix, Inc. |
Resequencing methods for identification of sequence variants
|
US8093043B2
(en)
*
|
2008-06-04 |
2012-01-10 |
New York University |
β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
|
DK2310517T3
(en)
*
|
2008-07-11 |
2016-06-06 |
Inst Nat De La Rech Agronomique (Inra) |
Novel mutant yeast strains having a capability to accumulate a large amount of lipids
|
EP2324044A4
(de)
|
2008-08-04 |
2012-04-25 |
Univ Miami |
Sting (stimulator von interferongenen) als regulator angeborener immunreaktionen
|
WO2010033854A2
(en)
|
2008-09-19 |
2010-03-25 |
Synageva Biopharma Corp. |
Avian derived fusion proteins
|
WO2010042490A1
(en)
*
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
A single lentiviral vector system for induced pluripotent (ips) stem cells derivation
|
WO2010075143A1
(en)
|
2008-12-22 |
2010-07-01 |
Monsanto Technology Llc |
Genes and uses for plant enhancement
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
EP2206723A1
(de)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modulare DNA-bindende Domänen
|
CA2757178C
(en)
|
2009-04-03 |
2020-05-19 |
Medical Research Council |
Mutants of activation-induced cytidine deaminase (aid) and methods of use
|
AU2010239381B2
(en)
|
2009-04-20 |
2015-01-15 |
Monsanto Technology Llc |
Multiple virus resistance in plants
|
WO2011002988A1
(en)
|
2009-07-01 |
2011-01-06 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (scid)
|
EP2456876A2
(de)
|
2009-07-24 |
2012-05-30 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für zytokin-zytokin-signalwege
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
US20110035816A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Ostertag Eric M |
Genetically Modified Rat Models for Drug Metabolism
|
EP2467013A2
(de)
|
2009-08-20 |
2012-06-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für schmerz
|
US20120315670A1
(en)
|
2009-11-02 |
2012-12-13 |
Gen9, Inc. |
Compositions and Methods for the Regulation of Multiple Genes of Interest in a Cell
|
PL2510096T5
(pl)
|
2009-12-10 |
2018-06-29 |
Regents Of The University Of Minnesota |
Modyfikacja DNA zależna od efektora TAL
|
CA2798988C
(en)
|
2010-05-17 |
2020-03-10 |
Sangamo Biosciences, Inc. |
Tal-effector (tale) dna-binding polypeptides and uses thereof
|
CA2806233C
(en)
|
2010-07-26 |
2021-12-07 |
Trianni, Inc. |
Transgenic animals and methods of use
|
DE102010041958A1
(de)
|
2010-10-04 |
2012-04-05 |
Medicyte Gmbh |
Geeignete Hepatozyten für in-vitro Genotoxitätstests
|
US10457935B2
(en)
|
2010-11-12 |
2019-10-29 |
Gen9, Inc. |
Protein arrays and methods of using and making the same
|
IL280133B2
(en)
|
2010-11-12 |
2023-04-01 |
Gen9 Inc |
Methods and devices for the synthesis of nucleic acids
|
JP6092782B2
(ja)
|
2010-11-16 |
2017-03-08 |
エクセリミューン, インコーポレイテッド |
組換えタンパク質の製造方法
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
EP2734632A1
(de)
|
2011-07-21 |
2014-05-28 |
The Regents of the University of California |
Transkriptionsfaktoren zur herstellung von zelluloseabbauenden enzymen
|
ES2737957T3
(es)
|
2011-08-26 |
2020-01-17 |
Gen9 Inc |
Composiciones y métodos para el ensamblaje de alta fidelidad de ácidos nucleicos
|
US9150853B2
(en)
|
2012-03-21 |
2015-10-06 |
Gen9, Inc. |
Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
|
CA2868473A1
(en)
|
2012-03-26 |
2013-10-03 |
Pronutria, Inc. |
Nutritive fragments, proteins and methods
|
CN104603286B
(zh)
|
2012-04-24 |
2020-07-31 |
Gen9股份有限公司 |
在体外克隆中分选核酸和多重制备物的方法
|
BR112014031891A2
(pt)
|
2012-06-19 |
2017-08-01 |
Univ Minnesota |
direcionamento genético nas plantas utilizando vírus de dna
|
LT2864531T
(lt)
|
2012-06-25 |
2019-03-12 |
Gen9, Inc. |
Nukleorūgšties konstravimo ir aukšto produktyvumo sekvenavimo būdai
|
EP2690177B1
(de)
|
2012-07-24 |
2014-12-03 |
Technische Universität Dresden |
Protein mit Rekombinase-Aktivität zur ortspezifischen DNA-Rekombination
|
CN104968193B
(zh)
|
2012-11-01 |
2021-02-09 |
塞尔克蒂斯股份有限公司 |
用于生成治疗性蛋白质的植物
|
TR201808715T4
(tr)
|
2012-12-21 |
2018-07-23 |
Cellectis |
Düşük soğuk indüklü tatlandırması olan patatesler.
|
AU2014207618A1
(en)
|
2013-01-16 |
2015-08-06 |
Emory University |
Cas9-nucleic acid complexes and uses related thereto
|
US10113162B2
(en)
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
EP2810952A1
(de)
|
2013-06-03 |
2014-12-10 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Neuartige Schädlingsbekämpfungsverfahren
|
EP2927685A1
(de)
|
2014-04-02 |
2015-10-07 |
Medicyte GmbH |
Geeignete Hepatozyten für In-vitro-Hepatitistests
|
US10301637B2
(en)
|
2014-06-20 |
2019-05-28 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
CN106460022B
(zh)
|
2014-06-24 |
2018-06-05 |
加州大学董事会 |
木糖甙木糖醇寡聚物的生产方法
|
FR3028527A1
(fr)
|
2014-11-13 |
2016-05-20 |
Pivert |
Identification de facteurs de transcription de yarrowia lipolytica
|
RU2017138918A
(ru)
|
2015-04-13 |
2019-05-13 |
Фраунхофер-Гезелльшафт Цур Фердерунг Дер Ангевандтен Форшунг Е.Ф. |
Новые способы борьбы с афлатоксином и грибковыми инфекциями
|
CN106191041B
(zh)
*
|
2015-04-30 |
2020-12-29 |
杭州菁因康生物科技有限公司 |
基因打靶方法
|
US20180291353A1
(en)
|
2015-05-28 |
2018-10-11 |
The Regents Of The University Of California |
Monofunctional aldehyde and alcohol dehydrogenases for production of fuels and commodity chemicals
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
WO2017128039A1
(zh)
*
|
2016-01-26 |
2017-08-03 |
浙江大学 |
基因组合及其用途
|
WO2017134601A1
(en)
|
2016-02-02 |
2017-08-10 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad3a/b/c genes
|
CN109661403A
(zh)
|
2016-08-05 |
2019-04-19 |
嘉吉公司 |
前导序列修饰的葡糖淀粉酶多肽和具有增强的生物产物产生的工程化的酵母菌株
|
CA3035084A1
(en)
|
2016-08-26 |
2018-03-01 |
Board Of Trustees Of Michigan State University |
Transcription factors to improve resistance to environmental stress in plants
|
CA3042857A1
(en)
|
2016-11-16 |
2018-05-24 |
Cellectis |
Methods for altering amino acid content in plants through frameshift mutations
|
AU2018260469A1
(en)
|
2017-04-25 |
2019-11-14 |
Cellectis |
Alfalfa with reduced lignin composition
|
US11046969B2
(en)
|
2017-05-24 |
2021-06-29 |
Epiplanta Biotech Ltd. |
Transgenic plant and the method for producing the same
|
WO2018228961A1
(en)
|
2017-06-12 |
2018-12-20 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Genetic tools and procedure for the phenotypic identification of the genotype of transgenic diploid organisms
|
JP7402503B2
(ja)
|
2017-06-14 |
2023-12-21 |
テクニスチェ ユニベルシタト ドレスデン |
デザイナーdna組換え酵素を利用したゲノムを遺伝的に改変するための方法及び手段
|
KR20220104847A
(ko)
|
2017-06-30 |
2022-07-26 |
인스크립타 인코포레이티드 |
자동 세포 처리 방법, 모듈, 기기 및 시스템
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
US10443074B2
(en)
|
2017-09-30 |
2019-10-15 |
Inscripta, Inc. |
Modification of cells by introduction of exogenous material
|
CA3087266A1
(en)
|
2018-01-09 |
2019-07-18 |
Cibus Us Llc |
Shatterproof genes and mutations
|
US10435662B1
(en)
|
2018-03-29 |
2019-10-08 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
US10376889B1
(en)
|
2018-04-13 |
2019-08-13 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
WO2019209926A1
(en)
|
2018-04-24 |
2019-10-31 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
AU2019292919A1
(en)
|
2018-06-30 |
2021-03-11 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US11965154B2
(en)
|
2018-08-30 |
2024-04-23 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
EP3986909A4
(de)
|
2019-06-21 |
2023-08-02 |
Inscripta, Inc. |
Genomweite rationell gestaltete mutationen, die zu einer erhöhten lysinproduktion in e. coli führen
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
AU2020299569A1
(en)
|
2019-07-01 |
2022-01-20 |
Trianni, Inc. |
Transgenic mammals and methods of use
|
WO2021003152A1
(en)
|
2019-07-01 |
2021-01-07 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
SG11202111943UA
(en)
|
2019-07-02 |
2021-11-29 |
Hutchinson Fred Cancer Res |
Recombinant ad35 vectors and related gene therapy improvements
|
US11939588B2
(en)
|
2019-10-17 |
2024-03-26 |
Board Of Trustees Of Michigan State University |
Elevated resistance to insects and plant pathogens without compromising seed production
|
EP3825408A1
(de)
|
2019-11-19 |
2021-05-26 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Verfahren zur insektenschädlingsbekämpfung für mehrere arten
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
CN116997651A
(zh)
|
2021-01-19 |
2023-11-03 |
J·大卫格莱斯顿研究所-根据J·大卫格莱斯顿遗嘱的遗嘱信托 |
用于增强人t细胞功能的基因激活靶标
|
CN117440753A
(zh)
|
2021-05-05 |
2024-01-23 |
特里安尼公司 |
表达嵌合马科动物-啮齿动物抗体的转基因啮齿动物及其使用方法
|
CA3235395A1
(en)
|
2021-11-10 |
2023-05-19 |
Peter Burrows |
Transgenic mammals and methods of use thereof
|
WO2023150393A2
(en)
|
2022-02-07 |
2023-08-10 |
Ensoma, Inc. |
Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids
|
WO2023156906A1
(en)
|
2022-02-15 |
2023-08-24 |
Futuragene Israel Ltd |
A bacillus thuringiensis pesticidal protein (bt pp) combination useful for plant protection
|